Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:01 pm Sale | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Kynam Capital Management, LP | 5,840,567 8.770% | -659,433![]() (-10.15%) | Filing History |
| 2026-05-15 2:37 pm Sale | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Bellevue Group AG | 1,200,000 1.500% | -2,417,669![]() (-66.83%) | Filing History |
| 2026-05-12 10:18 am Sale | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORP STT | 2,804,168 4.200% | -593,545![]() (-17.47%) | Filing History |
| 2026-05-06 11:06 am Sale | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | FMR LLC | 3,749,048 5.600% | -1,108,620![]() (-22.82%) | Filing History |
| 2026-04-29 5:36 pm Purchase | 2026-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | VANGUARD CAPITAL MANAGEMENT LLC | 3,446,795 5.170% | 3,446,795![]() (New Position) | Filing History |
| 2026-03-26 5:16 pm Sale | 2026-03-13 | 13G | CELLDEX THERAPEUTICS INC C CLDX | VANGUARD GROUP INC | 0 0.000% | -3,046,331![]() (Position Closed) | Filing History |
| 2026-03-10 6:41 pm Sale | 2025-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management, L.P. | 1,758,357 2.600% | -2,706,043![]() (-60.61%) | Filing History |
| 2026-02-10 11:21 am Purchase | 2025-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Wellington Management Group LLP | 8,079,608 12.200% | 684,862![]() (+9.26%) | Filing History |
| 2026-02-09 06:26 am Purchase | 2025-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | STATE STREET CORP STT | 3,397,713 5.100% | 1,106,259![]() (+48.28%) | Filing History |
| 2025-11-14 7:58 pm Purchase | 2025-08-18 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Bellevue Group AG | 3,617,669 5.400% | 3,617,669![]() (New Position) | Filing History |
| 2025-11-14 5:08 pm Sale | 2025-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,028,335 4.600% | -321,665![]() (-9.60%) | Filing History |
| 2025-11-14 12:19 pm Sale | 2025-09-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | T. Rowe Price Associates, Inc. | 2,382,701 3.600% | -1,174,435![]() (-33.02%) | Filing History |
| 2025-11-07 08:18 am Purchase | 2025-10-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Wellington Management Group LLP | 7,394,746 11.100% | 2,162,420![]() (+41.33%) | Filing History |
| 2025-08-14 2:59 pm Sale | 2025-06-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Eventide Asset Management, LLC | 1,356,186 2.000% | -1,975,819![]() (-59.30%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Wellington Management Group LLP | 5,232,326 7.900% | -3,121,825![]() (-37.37%) | Filing History |
| 2025-07-10 4:10 pm Purchase | 2025-07-02 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management, L.P. | 4,464,400 6.700% | 2,780,368![]() (+165.10%) | Filing History |
| 2025-05-15 11:48 am Purchase | 2025-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Kynam Capital Management, LP | 6,500,000 9.790% | 1,435,793![]() (+28.35%) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Wellington Management Group LLP | 8,354,151 12.600% | -889,448![]() (-9.62%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | BlackRock, Inc. BLK | 4,819,293 7.300% | -661,377![]() (-12.07%) | Filing History |
| 2025-04-10 4:05 pm Purchase | 2025-04-03 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Commodore Capital LP | 3,350,000 5.000% | 3,350,000![]() (New Position) | Filing History |

